As precision medicine tools evolve, it may be possible to tailor safe, effective, and durable obesity interventions for these diverse subgroups
Therefore, GLP-1RAs have emerged as one of the recommended pharmacological interventions for type 2 diabetes mellitus, especially for patients with cardiovascular risk factors and coexisting comorbidities (e.g., chronic kidney disease) [5]
By filling three-quarters of your plate with vegetables, legumes, and plant-based foods, and reserving one-quarter for protein and healthy fats, you naturally eat in a way that lowers inflammation, improves satiety, and supports metabolic health
Within this framework, anti-obesity medications (AOMs) emerge as a supportive strategy under pharmacotherapy, which is one of the three main evidence-based approaches to obesity treatment [11, 12]